143 related articles for article (PubMed ID: 12664950)
1. Unique risks to volunteers in HIV vaccine trials.
Frey SE
J Investig Med; 2003 Feb; 51 Suppl 1():S18-20. PubMed ID: 12664950
[TBL] [Abstract][Full Text] [Related]
2. Domestic AIDS vaccine trials: addressing the potential for social harm to the subjects of human experiments.
Leider PA
Calif Law Rev; 2000; 88():1185-232. PubMed ID: 11067733
[TBL] [Abstract][Full Text] [Related]
3. The use of Zairian children in HIV vaccine experimentation: a cross-cultural study in medical ethics.
Nairn TA
Annu Soc Christ Ethics; 1993; ():223-43. PubMed ID: 12568073
[No Abstract] [Full Text] [Related]
4. Setting the record straight: IAPAC's HIV vaccine initiative. International Association of Physicians in AIDS Care.
Zuniga J
J Int Assoc Physicians AIDS Care; 1997 Nov; 3(11):38-9. PubMed ID: 11364813
[TBL] [Abstract][Full Text] [Related]
5. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
Slack CM
Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209
[No Abstract] [Full Text] [Related]
6. Required HIV antibody testing, social risk, and HIV-vaccine efficacy trials.
MacQueen KM; Buchbinder SP; Douglas JM; Judson FN; McKirnan DJ; Bartholow BN
AIDS Public Policy J; 1996; 11(2):104-12. PubMed ID: 10915243
[No Abstract] [Full Text] [Related]
7. A review of vaccine research and development: the human immunodeficiency virus (HIV).
Girard MP; Osmanov SK; Kieny MP
Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298
[TBL] [Abstract][Full Text] [Related]
8. Relative versus absolute standards for everyday risk in adolescent HIV prevention trials: expanding the debate.
Snyder J; Miller CL; Gray G
Am J Bioeth; 2011 Jun; 11(6):5-13. PubMed ID: 21678205
[TBL] [Abstract][Full Text] [Related]
9. The concept of minimal risk: the need for better guidance on the ethics review process.
Wada K
Am J Bioeth; 2011 Jun; 11(6):27-9. PubMed ID: 21678213
[No Abstract] [Full Text] [Related]
10. Clinical research with healthy volunteers: an ethical framework.
Miller FG
J Investig Med; 2003 Feb; 51 Suppl 1():S2-5. PubMed ID: 12664947
[TBL] [Abstract][Full Text] [Related]
11. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
12. Social impact of preventive HIV vaccine clinical trial participation: a model of prevention, assessment and intervention.
Allen M; Lau CY
Soc Sci Med; 2008 Feb; 66(4):945-51. PubMed ID: 18162272
[TBL] [Abstract][Full Text] [Related]
13. National vaccine effort seen as insufficient.
AIDS Alert; 1998 Jan; 13(1):4-6. PubMed ID: 11364864
[TBL] [Abstract][Full Text] [Related]
14. Provision of HIV treatment in HIV preventive vaccine trials: a developing country perspective.
Slack C; Stobie M; Milford C; Lindegger G; Wassenaar D; Strode A; Ijsselmuiden C
Soc Sci Med; 2005 Mar; 60(6):1197-208. PubMed ID: 15626517
[TBL] [Abstract][Full Text] [Related]
15. Willingness to participate in HIV vaccine research in a peri-urban South African community.
Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ
Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005
[TBL] [Abstract][Full Text] [Related]
16. (Un)risky business: adolescents and HIV prevention trials.
Philpott S
Am J Bioeth; 2011 Jun; 11(6):17-9. PubMed ID: 21678207
[No Abstract] [Full Text] [Related]
17. Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS vaccine trials.
Maek-A-Nantawat W; Pitisuttithum P; Phonrat B; Bussaratid V; Naksrisook S; Peonim W; Thantamnu N; Muanaum R
J Med Assoc Thai; 2003 Apr; 86(4):299-307. PubMed ID: 12757073
[TBL] [Abstract][Full Text] [Related]
18. A relative standard for minimal risk is unnecessary and potentially harmful to children: lessons from the Phambili trial.
Nelson RM
Am J Bioeth; 2011 Jun; 11(6):14-6. PubMed ID: 21678206
[No Abstract] [Full Text] [Related]
19. Assessing research risks systematically: the net risks test.
Wendler D; Miller FG
J Med Ethics; 2007 Aug; 33(8):481-6. PubMed ID: 17664310
[TBL] [Abstract][Full Text] [Related]
20. Social and behavioral science in HIV vaccine trials: a gap assessment of the literature.
Lau CY; Stansbury JP; Gust DA; Kafaar Z
Expert Rev Vaccines; 2009 Feb; 8(2):179-90. PubMed ID: 19196198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
